Cochlear Investor Relations Material
Cochlear Limited is a developer, manufacturer and marketer of implantable hearing solutions for adults and children worldwide. It provides in-the-ear devices that restore functional hearing to people with sensorineural, or ‘brain-based’, hearing loss; a condition caused by damage to the inner ear or auditory nerve. Cochlear products are sold through OEM partnerships with medical device companies, who integrate them into their products and distribute them through their own sales networks to physicians worldwide. Customers for these products include audiologists and surgeons involved in cochlear implant surgery, as well as hospitals, government health agencies and other users of off-the-shelf implanted components such as hearing aid dispensers.
Key slides for Cochlear Limited
Webull vs Robinhood: Which Platform Suits You?
In the competitive world of online trading platforms, Webull and Robinhood have emerged as two of the top choices for investors.
24 Nov 2023
Norway's Sovereign Wealth Fund: Transforming Oil Wealth into Lasting Prosperity
But what makes Norway’s striking of oil so fundamentally different from its worse faring counterparts? The answer is in large part its Norwegian Government Pension fund, and Norges Bank Investment Management
24 Nov 2023
Danaher Business System and Acquisition History
Since the early 1990s, Danaher's management team has transformed a group of under-performing industrial manufacturing companies into a global powerhouse in life sciences and diagnostics.
22 Nov 2023